Table 3.
4 weeks | 8 weeks | 12 weeks | 16 weeks | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Control | GW3 | Estimated difference adjusted for sex | p value | Control | GW3 | Estimated difference adjusted for sex | p value | Control | GW3 | Estimated difference adjusted for sex | p value | Control | GW3 | Estimated difference adjusted for sex | p value | |
Number | 5 | 7 | 8 | 13 | 12 | 8 | 18 | 8 | ||||||||
Total tissue area (mm2) | 4.55 | 4.36 | −0.18 | 0.788 | 6.27 | 6.42 | 0.4 | 0.3 | 7.03 | 6.61 | 0.14 | 0.733 | 6.77 | 7.28 | 0.22 | 0.733 |
Bone area (mm2) | 1.06 | 1.25 | 0.11 | 0.664 | 1.4 | 2.16 | 0.82*** | 0.001 | 1.27 | 1.61 | 0.3 | 0.16 | 1.39 | 1.53 | 0.17 | 0.58 |
Bone perimeter (mcm) | 41.39 | 38.62 | −3.77 | 0.714 | 54.18 | 60.74 | 7.4 | 0.288 | 47.27 | 44.43 | −2.51 | 0.779 | 44.53 | 47.68 | 5.02 | 0.542 |
Osteoblast surface (mm) | 9.59 | 8.88 | −1.48 | 0.61 | 11.31 | 16.8 | 5.91 | 0.144 | 12.14 | 21.66 | 11.60* | 0.04 | 10.28 | 14.92 | 3.62 | 0.255 |
Osteoid surface (mm) | 0.42 | 2.18 | 1.44 | 0.093 | 1.92 | 4.98 | 3.15* | 0.046 | 0.99 | 5.5 | 4.94* | 0.022 | 1.9 | 3.12 | 0.98 | 0.446 |
N.Oc per eroded surface (N.Oc/mm) | 45.18 | 245.72 | 233.31 | 0.077 | 95.32 | 120.99 | 26.8 | 0.52 | 89.26 | 102.95 | −29.07 | 0.735 | 74.18 | 66.57 | −9.05 | 0.829 |
Eroded surface (mm) | 1.46 | 0.92 | −0.64 | 0.074 | 0.94 | 0.81 | −0.07 | 0.597 | 1.31 | 0.87 | −0.33 | 0.359 | 0.98 | 0.72 | −0.22 | 0.329 |
Proliferative zone growth plate (mcm) | 302.83 | 210.29 | −92.78* | 0.023 | 195.73 | 123.56 | −63.97 | 0.063 | 166.01 | 150.84 | −8.67 | 0.485 | 130.73 | 123.35 | −10.93 | 0.305 |
Hypertrophic zone growth plate (mcm) | 179.64 | 126.15 | −48.66 | 0.244 | 88.81 | 70.4 | −15.06 | 0.405 | 75.44 | 75.02 | 1.78 | 0.735 | 62.14 | 62.62 | −0.46 | 0.89 |
GWS = gestation week 3; N.Oc = Osteoclast Number;
= p < 0.05;
= p < 0.01;
= p< 0.001